无糖尿病视网膜病变的糖尿病患者存在内层视网膜结构与功能损害的证据
该研究基于人群研究数据,纳入505只眼(其中134例糖尿病但无临床可见视网膜血管改变),评估内层视网膜结构与功能。结果显示糖尿病组神经节细胞层和内丛状层显著变薄,除微视野外功能测试显著下降;结构-功能关系符合神经模型预测,FDT可捕捉结构损失之外的额外损害。
要点
- 无临床血管改变的糖尿病患者已出现神经节细胞层和内丛状层显著变薄。
- 糖尿病组除微视野外,视力、对比敏感度、微视野和FDT等功能测试显著受损。
- FDT可捕捉结构损失之外的额外功能损害,提示功能测试或可优化以提高早期敏感性。
核心结论
- 功能和结构测量支持糖尿病早期神经元丢失。
- 结构-功能关系遵循既有神经模型的预测。
- 功能测试可改进为在黄斑区全总和条件下运行,从而对早期丢失更敏感。
研究设计与样本
- 基于大型人群研究的横断面分析,纳入505只眼,其中134例糖尿病且无临床可见视网膜血管改变。
- 功能测试包括最佳矫正视力、Pelli-Robson对比敏感度、中间视觉微视野和频域倍增技术视野(FDT)。
- 所有参与者均采集黄斑光学相干断层扫描体积扫描,并将神经节细胞层厚度转换为局部神经节细胞计数。
主要发现
- 糖尿病组神经节细胞层和内丛状层显著更薄(P < 0.05),黄斑视网膜神经纤维层和外层视网膜无显著差异。
- 除微视野外,所有功能测试在糖尿病患者中均显示显著下降(P < 0.05)。
- FDT和微视野均与神经节细胞计数显著相关(P < 0.05),符合神经模型对部分总和条件的预测。
- FDT捕捉到结构损失无法解释的额外显著损害(P = 0.03)。
关键数值与推荐
- 糖尿病组神经节细胞层和内丛状层厚度显著更薄,P < 0.05。
- 除微视野外功能测试显著下降,P < 0.05。
- FDT和微视野与神经节细胞计数显著相关,P < 0.05。
- FDT额外显著损害P = 0.03。
临床怎么用
- 对于无临床可见视网膜血管改变的糖尿病患者,应关注内层视网膜结构和功能的早期损害。
- 功能测试如FDT和微视野可辅助评估糖尿病早期神经元损害。
- 未来可优化功能测试至黄斑区全总和条件以提高早期丢失敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide structural and functional evidence of inner retinal loss in diabetes prior to vascular changes and interpret the structure-function relationship in the context of an established neural model. METHODS: Data from one eye of 505 participants (134 with diabetes and no clinically evident vascular alterations of the retina) were included in this analysis. The data were collected as part of a large population-based study. Functional tests included best-corrected visual acuity, Pelli-Robson contrast sensitivity, mesopic microperimetry, and frequency doubling technology perimetry (FDT). Macular optical coherence tomography volume scans were collected for all participants. To interpret the structure-function relationship in the context of a neural model, ganglion cell layer (GCL) thickness was converted to local ganglion cell (GC) counts. RESULTS: The GCL and inner plexiform layer were significantly thinner in participants with diabetes (P < 0.05), with no significant differences in the macular retinal nerve fiber layer or the outer retina. All functional tests except microperimetry showed a significant loss in diabetic patients (P < 0.05). Both FDT and microperimetry showed a significant relationship with the GC count (P < 0.05), consistent with predictions from a neural model for partial summation conditions. However, the FDT captured additional significant damage (P = 0.03) unexplained by the structural loss. CONCLUSIONS: Functional and structural measurements support early neuronal loss in diabetes. The structure-function relationship follows the predictions from an established neural model. Functional tests could be improved to operate in total summation conditions in the macula, becoming more sensitive to early loss.
引用
- Montesano G, Ometto G, Higgins BE, et al. Evidence for Structural and Functional Damage of the Inner Retina in Diabetes With No Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2021. PMID: 33760040. doi:10.1167/iovs.62.3.35
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。